Abstract
Chromosomal microarray analysis (CMA) can identify submicroscopic pathogenic copy number changes (CNC) that are too small to be detected by standard chromosome analysis. The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine recommends use of CMA for prenatal diagnosis of fetuses with one or more major structural abnormalities identified on ultrasound, or for evaluation of intrauterine fetal death or stillbirth.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
